Genetic engineering to block immune destruction of transplanted cells succeeds in macaques.
A major challenge in the development of cell therapies is how to stop a patient’s immune response from killing transplanted cells derived from an unmatched donor. Various approaches to address this problem are under investigation, but a particularly elegant solution would be to create ‘universal’ donor cells that could be transplanted into any recipient without being rejected. In a study in Nature Biotechnology, Schrepfer and colleagues1 describe an exciting step toward this goal in a non-human primate model. Using donor cells with three genetic modifications — deletion of human leukocyte antigen (HLA) class I and II molecules and overexpression of CD47 — the authors demonstrate sustained immune evasion by human and macaque induced pluripotent stem cells (iPSCs) in immunocompetent rhesus macaques. This work is important because it is likely to pave the way to cell therapies that avoid immune rejection without the need for immunosuppression.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
209,00 € per year
only 17,42 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
Fig. 1: Cellular engineering to generate hypoimmune cells.
References
Hu, X. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01784-x (2023).
Article
PubMed
Google Scholar
Chen, H. et al. Biol. Res.48, 59 (2015).
Article
PubMed
PubMed Central
Google Scholar
Riolobos, L. et al. Mol. Ther.21, 1232–1241 (2013).
Article
CAS
PubMed
PubMed Central
Google Scholar
Mattapally, S. et al. J. Am. Heart Assoc.7, e010239 (2018).
Article
CAS
PubMed
PubMed Central
Google Scholar
Kadri, N. et al. Curr. Top. Microbiol. Immunol.395, 95–114 (2016).
CAS
PubMed
Google Scholar
Gornalusse, G. G. et al. Nat. Biotechnol.35, 765–772 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Quatrini, L. et al. Nat. Immunol.19, 954–962 (2018).
Article
CAS
PubMed
PubMed Central
Google Scholar
Deuse, T. et al. J. Exp. Med.218, e20200839 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Deuse, T. et al. Nat. Biotechnol.37, 252–258 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Gravina, A. et al. Nat. Biotechnol.41, 717–727 (2023).
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao, L., Teklemariam, T. & Hantash, B. M. Stem Cell Res.13, 342–354 (2014).
Article
CAS
PubMed
Google Scholar
Download references
Author information
Authors and Affiliations
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Asuncion Borrero Borrego & Saar Gill
Salamanca Biomedical Institute (IBSAL), University of Salamanca, Salamanca, Spain
Asuncion Borrero Borrego
Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, Philadelphia, PA, USA
Saar Gill
Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA
Saar Gill
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
About this article
Cite this article
Borrero Borrego, A., Gill, S. Hypoimmune cells resist rejection in monkeys.
Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-02013-1
Download citation
Published: 23 October 2023
DOI: https://doi.org/10.1038/s41587-023-02013-1
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-023-02013-1